{"id":"NCT01212770","sponsor":"Amgen","briefTitle":"PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis","officialTitle":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) in Subjects With Active Psoriatic Arthritis and a Qualifying Psoriasis Lesion","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-09-30","primaryCompletion":"2012-08-21","completion":"2017-02-09","firstPosted":"2010-10-01","resultsPosted":"2014-05-20","lastUpdate":"2020-05-06"},"enrollment":505,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Psoriatic Arthritis"],"interventions":[{"type":"DRUG","name":"Apremilast 20mg","otherNames":["CC-10004"]},{"type":"DRUG","name":"Apremilast 30mg","otherNames":["CC-10004"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Apremilast 20 mg","type":"EXPERIMENTAL"},{"label":"Apremilast 30 mg","type":"EXPERIMENTAL"},{"label":"Placebo + 20 mg Apremilast","type":"PLACEBO_COMPARATOR"},{"label":"Placebo + 30 mg Apremilast","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis and a qualifying psoriasis lesion.\n\nApremilast is proposed to improve signs and symptoms of psoriatic arthritis (tender and swollen joints, pain, physical function) in treated patients.","primaryOutcome":{"measure":"Percentage of Participants With an American College of Rheumatology 20% (ACR20) Response at Week 16","timeFrame":"Baseline and Week 16","effectByArm":[{"arm":"Placebo","deltaMin":18.3,"sd":null},{"arm":"Apremilast 20 mg","deltaMin":28.4,"sd":null},{"arm":"Apremilast 30 mg","deltaMin":40.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG002","p":"<0.0001"},{"comp":"OG000 vs OG001","p":"0.0295"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":10,"exclusionCount":3},"locations":{"siteCount":91,"countries":["United States","Australia","Canada","Finland","France","Germany","Italy","Lithuania","Poland","Romania","Russia","Slovakia","South Korea","Spain","Switzerland","United Kingdom"]},"refs":{"pmids":["26792812","37316690","34536218","31909868","31077258","30018799"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":168},"commonTop":["Diarrhoea","Nausea","Headache","Upper respiratory tract infection","Nasopharyngitis"]}}